Lixisenatide as add-on therapy to basal insulin

Lixisenatide as add-on therapy to basal insulin

Dominique Xavier Brown, Emma Louise Butler, Marc Evans Diabetes Department, University Hospital Llandough, Cardiff, UK Abstract: Many patients with type 2 diabetes mellitus do not achieve target glycosylated hemoglobin A1c levels despite optimally titrated basal insulin and satisfactory fasting pl...

Full description

Bibliographic Details
Main Authors:	Brown DX, Butler EL, Evans M
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-12-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/lixisenatide-as-add-on-therapy-to-basal-insulin-peer-reviewed-article-DDDT

Similar Items

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
by: Åsa Ericsson, et al.
Published: (2018-01-01)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
by: Tomislav Božek, et al.
Published: (2018-03-01)

Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
by: Diego Bellido, MD, PhD, et al.
Published: (2018-01-01)

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus
by: Fournier, Marie, et al.
Published: (2014-10-01)

Efficacy of once‐daily glucagon‐like peptide‐1 receptor agonist lixisenatide as an add‐on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual‐level pooled analysis of phase III studies
by: Fuqiang Liu, et al.
Published: (2021-08-01)

Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020-01-01)

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data
by: Jaime A. Davidson, et al.
Published: (2020-01-01)

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients
by: Chitrabhanu Ballav, et al.
Published: (2020-07-01)

Glucagon-like peptide-1 receptor agonists, selection within the class. The rational combination of insulin glargine 100 + lixisenatide
by: M. V. Martjanova, et al.
Published: (2020-05-01)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
by: Petersen AB, et al.
Published: (2013-06-01)

Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2
by: S. К. Zyryanov, et al.
Published: (2019-01-01)

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
by: Berlie H, et al.
Published: (2012-07-01)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
by: von Websky K, et al.
Published: (2013-11-01)

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
by: Hunter Kerry, et al.
Published: (2012-03-01)

New approaches to basal insulin therapy in diabetes
by: Ashwell, Simon Guy
Published: (2005)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Sami N. Nasrallah, et al.
Published: (2012-04-01)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Sami N. Nasrallah, et al.
Published: (2012-01-01)

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
by: Pfohl M, et al.
Published: (2015-11-01)

Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes
by: Gautam Das, et al.
Published: (2018-08-01)

Concentrated insulins: the new basal insulins
by: Lamos EM, et al.
Published: (2016-03-01)

Future of newer basal insulin
by: S V Madhu, et al.
Published: (2013-01-01)

Degludec insulin: A novel basal insulin
by: Sanjay Kalra, et al.
Published: (2011-01-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

Acute Effects of Lixisenatide on Energy Intake in Healthy Subjects and Patients with Type 2 Diabetes: Relationship to Gastric Emptying and Intragastric Distribution
by: Ryan Jalleh, et al.
Published: (2020-07-01)

Cardiovascular effects of basal insulins
by: Mannucci E, et al.
Published: (2015-07-01)

Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy
by: Pešić Milica, et al.
Published: (2007-01-01)

The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
by: Katsiaryna Sikorskaya, BSN, RN, CSN, et al.
Published: (2021-03-01)

How to Turn On an Ancient Metabolic Enzyme? Add Insulin and Deacetylate.
by: Richard Robinson
Published: (2015-09-01)

Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
by: Kutoh Eiji
Published: (2011-03-01)

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
by: Chan WB, et al.
Published: (2017-12-01)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
by: Andrew Ahmann
Published: (2015-11-01)

Yoga as an add-on therapy in the management of migraine
by: Sachin Kumar Sharma, et al.
Published: (2020-01-01)

Gabapentin Add-On Therapy for Partial Seizures
by: J Gordon Millichap
Published: (2001-05-01)

Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012-08-01)

OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: G. A. Galkina, et al.
Published: (2015-10-01)

Controlled Delivery of Basal Level of Insulin
by: Oak, Mayura Arvind
Published: (2017)

Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes
by: Giampietro O, et al.
Published: (2013-02-01)

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
by: Martina Vettoretti, et al.
Published: (2019-03-01)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
by: Abe S, et al.
Published: (2011-07-01)

Cannot write session to /tmp/vufind_sessions/sess_i3ml1gsnhb6n1ivmpd8giur52f